Indeed, our data demonstrated that NRF2 knockdown effectively reversed HACE1-mediated decreased radiosensitivity of glioma cells and promoting effect of HACE1 on cellular GSH levels, strongly supporting the above hypothesis. The gene discussed is NFE2L2; the disease is central nervous system cancer.